about
Gene expression in tumor cells and stroma in dsRed 4T1 tumors in eGFP-expressing mice with and without enhanced oxygenationErythropoietin or darbepoetin for patients with cancerErythropoietin for patients with malignant diseaseErythropoietin or Darbepoetin for patients with cancerHypoxic tumor cell modulates its microenvironment to enhance angiogenic and metastatic potential by secretion of proteins and exosomesTumor-endothelial interaction links the CD44(+)/CD24(-) phenotype with poor prognosis in early-stage breast cancerHypoxia and oxidative stress. Tumour hypoxia--therapeutic considerationsGlioblastoma Stem Cells Microenvironment: The Paracrine Roles of the Niche in Drug and RadioresistancePrediction of Cancer Drug Resistance and Implications for Personalized MedicineIn Vivo pO2 Imaging of Tumors: Oxymetry with Very Low-Frequency Electron Paramagnetic ResonanceAdvances in molecular imaging for breast cancer detection and characterizationDefining normoxia, physoxia and hypoxia in tumours-implications for treatment responseThe clinical importance of assessing tumor hypoxia: relationship of tumor hypoxia to prognosis and therapeutic opportunitiesRedox activation of metal-based prodrugs as a strategy for drug deliveryPositron emission tomography to assess hypoxia and perfusion in lung cancerKilling hypoxic cell populations in a 3D tumor model with EtNBS-PDTThe Role of the PERK/eIF2α/ATF4/CHOP Signaling Pathway in Tumor Progression During Endoplasmic Reticulum StressReducing Tumour Hypoxia via Oral Administration of Oxygen NanobubblesNrf2 is the key to chemotherapy resistance in MCF7 breast cancer cells under hypoxiaThe impact of O2 availability on human cancerUltrasound mediated delivery of oxygen and LLL12 loaded stimuli responsive microdroplets for the treatment of hypoxic cancer cells.Transplanting normal vascular proangiogenic cells to tumor-bearing mice triggers vascular remodeling and reduces hypoxia in tumorsNormalizing tumor microenvironment to treat cancer: bench to bedside to biomarkers.Spatial reorganization of Saccharomyces cerevisiae enolase to alter carbon metabolism under hypoxia.Probing NMR parameters, structure and dynamics of 5-nitroimidazole derivatives. Density functional study of prototypical radiosensitizers.Analysis of protein redox modification by hypoxia.Hyperoxia retards growth and induces apoptosis and loss of glands and blood vessels in DMBA-induced rat mammary tumorsCellular and cell-free studies of catalytic DNA cleavage by ruthenium polypyridyl complexes containing redox-active intercalating ligands.Tumor vascular changes mediated by inhibition of oncogenic signaling.Berberine Reverses Hypoxia-induced Chemoresistance in Breast Cancer through the Inhibition of AMPK- HIF-1α.A Predictive Mathematical Modeling Approach for the Study of Doxorubicin Treatment in Triple Negative Breast CancerSe-methylselenocysteine sensitizes hypoxic tumor cells to irinotecan by targeting hypoxia-inducible factor 1alpha.HIF-1 activation induces doxorubicin resistance in MCF7 3-D spheroids via P-glycoprotein expression: a potential model of the chemo-resistance of invasive micropapillary carcinoma of the breast.Oxygen as a regulator of cellular phenotypes in pregnancy and cancer.Expression and significance of hypoxia-inducible factor-1 alpha and MDR1/P-glycoprotein in human colon carcinoma tissue and cells.Inhibition of Na+/K+-ATPase induces hybrid cell death and enhanced sensitivity to chemotherapy in human glioblastoma cells.Tumor cycling hypoxia induces chemoresistance in glioblastoma multiforme by upregulating the expression and function of ABCB1Mathematical modeling of cancer progression and response to chemotherapy.Molecular and pharmacological strategies to overcome multidrug resistance.Evaluation of the "steal" phenomenon on the efficacy of hypoxia activated prodrug TH-302 in pancreatic cancer
P2860
Q21261284-A58F0E07-59B8-4659-87F5-3EFD2B0C7DFCQ24202335-54544E65-04ED-4E7F-943B-9615CA8C28AEQ24245427-833093BF-A900-4385-BD53-BA3AE20D2F86Q24245464-C12515EB-F07D-4BC9-80A8-3628E5077E27Q24604279-1A8293C3-A694-4C6B-84D8-89AF53C83F9EQ24652733-844CF642-A14E-4D99-AACB-C0326C221AC9Q24801771-96DA2217-90D8-47B6-A9CF-C977BA2F3125Q26765869-8D8040A3-64E0-4B09-89CD-CC114136DE68Q26770581-786FBD91-907B-4C3B-8987-1DF206F815B4Q26782107-C6847D2A-5883-42E9-9135-D8CC11B38972Q27000462-AC0870C7-92F2-46E9-88F4-20529E6D1D43Q27009437-37436E6E-E8D6-481B-9F08-71F8CEE9A873Q27025579-DC0919C2-3D4D-44B9-946E-577E1310C7ACQ27025736-A99B0A14-C3F3-4ECA-BC4E-7DD170D03C9DQ27026940-060B2B33-ABCE-4FAF-8DB6-8BD4D90F547DQ27324380-9355B2D3-1113-48B3-82A2-6F244289027AQ28068986-ADB7C155-F8F3-4DF9-BC3E-54817B19057DQ28468506-B3E82AE1-2AE4-4B46-B565-9FD95471BA30Q28828596-BFED955B-3A99-4706-8EEA-05AD465872E1Q29619884-1CD5B8FE-ED89-4A92-B02C-F15F8D53707DQ30360565-58B814D4-B4C6-46EE-A579-959D2E20E829Q30499092-D655A62A-C7F6-4165-9D07-96D88CAC74ABQ30542073-3F25FF48-BB6D-4B1E-AE5F-48617BB59322Q30543761-D874EAE2-7E4A-4CAB-9FC7-65DF7D96F77DQ30976910-B5EE26B1-AB56-45CE-8CCA-02F6298D3CE4Q33232231-0AAEBCB3-D264-4663-A953-7E686077871AQ33270954-0417F48D-EA13-42B8-B712-1D35CD486C78Q33670035-1599D6AE-2FB5-4CEE-B77B-D55EBC3117F3Q33671385-06201FEF-9A50-4FF9-B67E-E39D82ED77E9Q33837285-FE327404-E496-467C-A759-7FD493DAAE67Q33916210-5C63ABC9-BF64-49B8-9D0F-C6B4983A4B11Q34047866-38C64D74-15FE-4FD6-8A32-6D856DC409DEQ34118293-4B922FA1-1080-4B06-A9FC-94072AF3FD99Q34122203-FB78A753-57B4-44DA-B393-0BA08753401EQ34152742-E3F968D1-B265-48AE-BC44-8F5E6BDEB56EQ34309146-2D646AF7-21E6-44A9-B1CC-525AE086AE2AQ34402422-6653E011-3956-475A-9DBE-2892D498FE32Q34577219-C95F6FD4-1E1E-4825-B6C0-FAEFB7F5D755Q34734178-2A4A77D8-4D5E-473E-8854-02E0343BAB35Q34756921-F95F1AD4-987C-4B18-9B6E-837163F3FA1C
P2860
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Hypoxia and drug resistance.
@en
type
label
Hypoxia and drug resistance.
@en
prefLabel
Hypoxia and drug resistance.
@en
P2860
P356
P1476
Hypoxia and drug resistance.
@en
P2093
B A Teicher
P2860
P2888
P304
P356
10.1007/BF00689633
P577
1994-06-01T00:00:00Z
P6179
1018130502